Asset Details
Do you wish to reserve the book?
Enhancement of activation-induced T cell proliferation by SIRPG in a CD47-independent manner
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Enhancement of activation-induced T cell proliferation by SIRPG in a CD47-independent manner
Do you wish to request the book?
Enhancement of activation-induced T cell proliferation by SIRPG in a CD47-independent manner
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Enhancement of activation-induced T cell proliferation by SIRPG in a CD47-independent manner
2025
Overview
SIRPG, a primate-specific type 1 transmembrane protein in the Signal Regulatory Protein (SIRP) family, is predominantly expressed in T cells. It contains a short cytoplasmic domain, which does not contain any known signaling motif, and its only known ligand is CD47. Several genetic variations in SIRPG , including the V263A (rs6043409) polymorphism, linked to increased type 1 diabetes risk, highlight its potential importance. However, its expression and physiological role remain largely unclear due to its absence in rodents. Here, we demonstrate that SIRPG and GzmB exhibit near mutually exclusive expression in resting peripheral CD8+ T cells. We further show that SIRPG serves as a valuable marker for GzmK-expressing CD8+ T cells in peripheral blood and that its expression in both CD4+ and CD8+ T cells is upregulated by anti-CD3 stimulation, with further enhancement by the TNFα inhibitor adalimumab, but not certolizumab. While SIRPG ablation minimally affects T cell activation and IFNγ/TNFα production, it impairs the expression of mitosis-regulating genes like UBE2C and TOP2A , leading to reduced proliferation, and alters the expression of certain activation-induced surface molecules, including CRTAM. Notably, SIRPG-mediated proliferation and CRTAM expression are cell-autonomous and CD47-independent. Structural and functional analyses reveal that SIRPG-driven proliferation is independent of its extracellular D1 domain, not significantly affected by the V263 variant, but dependent on its cytoplasmic domain. Collectively, our findings offer novel insights into the expression, function, and mechanism of action of SIRPG in T cells.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Animals
/ CD47
/ CD8-Positive T-Lymphocytes - immunology
/ CD8-Positive T-Lymphocytes - metabolism
/ Diabetes mellitus (insulin dependent)
/ GZMB
/ GZMK
/ Humans
/ Ligands
/ Lymphocyte Activation - immunology
/ Mitosis
/ Proteins
/ Receptors, Immunologic - genetics
/ Receptors, Immunologic - immunology
/ Receptors, Immunologic - metabolism
/ SIRPG
/ Structure-function relationships
/ T cells
